Chandra Bhagat Pharma Ltd.

As of March 31, 2026, Chandra Bhagat Pharma Ltd. carries a market capitalization of 230.12M, placing it among publicly traded companies globally. Its enterprise value stands at 347.40M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of March 31, 2026, Chandra Bhagat Pharma Ltd. has 7.55M shares outstanding.

These figures are as of March 31, 2026.

As of March 31, 2026, Chandra Bhagat Pharma Ltd. maintains a current ratio of 1.50, meaning it holds 1.5x the short-term assets needed to cover near-term liabilities.

As of the close on October 19, 2026, Chandra Bhagat Pharma Ltd.'s stock has declined approximately 2.72% over the past 52 weeks. The 50-day moving average sits at 41.87, while the 200-day moving average is 49.43.

As of March 31, 2026, Chandra Bhagat Pharma Ltd. holds 47.79M in cash and equivalents against 165.07M in total debt, resulting in a net debt position of 133.97M. Total book value stands at 331.27M, with working capital of 291.87M providing operational flexibility.